Tracking solutions that use bar-codes have been in the clinical pathology laboratories for quite a few years and recently are being used in the anatomic pathology laboratories as well. Anatomic pathology specimens, slides tracking and blocks are helping to improve the laboratory efficiency, and for the betterment of patient care, and promotion of patient safety. Research laboratories are using surplus clinical material in the biorepositories are some of the other avenues which are being benefited from the tracking of anatomic pathology specimens.

Implementation of tracking is a complex procedure. Analysis of workflow in the laboratory is required before the implementation of tracking for the assurance that the solution meets the need of the laboratories. Analysis needs some modifications before the initiation and deployment of the tracking system which help in uncovering the practices. Tracking on the software needs certain notable changes in the workflow and also transmute in the laboratory culture. Preparation, buy-in, training, and accountability individual are important for the fortune of the process.

Market scope and structure analysis:

COVID-19 scenario analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the Anatomic Pathology Track and Trace Solutions market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
 

Increasing volumes of diagnostic tests which are been performed in anatomic pathology laboratories and the rising numbers of legal cases around cancer misdiagnosis are the key factors boosting the growth of the anatomic pathology track and trace solutions market.

The benefits of automatic labeling solutions and the rise in the consolidation amongst the anatomic pathology laboratories, increasing adoption of automated systems to improve the productivity of laboratories are the major factors driving the growth of this market.

On the other hand, higher implementation costs of the solutions in track and trace solutions in anatomic pathology laboratories are restraining the growth of the anatomic pathology track and trace solutions market.

New product launches to flourish the market:

On March 2nd, 2020, Leica Biosystemsintroducedcase management software to support Aperio AT2 DX System for Primary Diagnosis for cancer patients.

Surge in usage in pharmaceutical and biotechnological Companies applications:

Reference and independent laboratories, hospital laboratories, medical laboratories which are funded governments, research institutes, contract research organizations, and many other laboratories are the main consumers of the anatomic pathology tracking and tracing solutions market. The reference laboratories have the highest consumption rate amongst the end-users. The increase in the amount of cancer diagnostic tests being carried out in reference laboratories and the enlarging number of high reference laboratories around the world.

Key segments covered:

Key benefits of the report:

• This study presents the analytical depiction of the global Anatomic Pathology Track and Trace Solutions industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Anatomic Pathology Track and Trace Solutions market share.
• The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Anatomic Pathology Track and Trace Solutions market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global Anatomic Pathology Track and Trace Solutions market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Anatomic Pathology Track and Trace Solutions Market research report:

• What are the leading market players active in the Anatomic Pathology Track and Trace Solutions market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?